Patients with RA being treated with Methotrexate [MTX] are given folate supplements to avoid folate deficiency and MTX-dependent reduction in the production of dihydrofolate reductase and other folate-dependent enzymes (72, 73). Here, DHFR is linked to folate deficiency.